Karyopharm Therapeutics (KPTI) traded down -6.95 % during a 24 hours period ending at 10:11 AM Central Europe on Tuesday 27th. One Karyopharm Therapeutics stock can currently be bought for about USD 0.48 on popular exchanges. Current supply of Karyopharm Therapeutics stocks is 23.5 mn. Karyopharm Therapeutics has a current market capitalization of USD 11.2 mn and approximately USD 657.8 k worth of Karyopharm Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Karyopharm Therapeutics has traded -70.25 % down. Simple moving average of last 200 days is at USD 6.18. The highest price of past 52 weeks was recorded at USD 10.99 on 02/24/2026. 52 weeks low was at USD 0.31 on 10/15/2026.
Here is how related stocks have performed in the past 24 hours:
Air Industries (AIRI) traded down -1.92 % and now trades at USD 2.55. Current market capitalisation for Air Industries is USD 12.6 mn.
Smith Micro Software (SMSI) traded up 0.86 % and now trades at USD 2.35. Current market capitalisation for Smith Micro Software is USD 13 mn.
Sunation Energy (SUNE) traded up 2.58 % and now trades at USD 1.99. Current market capitalisation for Sunation Energy is USD 12.6 mn.
Biocardia (BCDA) traded down -2.17 % and now trades at USD 0.9. Biocardia has a market capitalisation of USD 13.3 mn.
Iridex (IRIX) traded flat 0 % and now trades at USD 0.75. Current market capitalisation for Iridex is USD 12.8 mn.
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. is an oncology-focused pharmaceutical company operating in the health care sector, specializing in biotechnology. The company offers combination therapies with dexamethasone for patients with pretreated multiple myeloma, as well as providing single-agent and combination activity against a variety of human cancers. Karyopharm Therapeutics serves patients in the United States, Germany, and Israel, and its official website is www.karyopharm.com . The company went public on the Nasdaq stock exchange on November 6, 2013.
